Cygnus Capital Advisors’s uniQure QURE Stock Holding History

Cygnus Capital Advisors’s Portfolio QURE Stock Details QURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-288	Closed	-$7	–	168
2025 Q4	$7	Buy	+288	New	+$11.1K	0.01%	123

Other funds holding QURE

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Cygnus Capital Advisors's QURE Position: Q1 2026 in Review

Cygnus Capital Advisors sold out of uniQure (QURE) in Q1 2026, closing a stake of 288 shares — an estimated $7 sold.

Cygnus Capital Advisors first reported a position in QURE in Q4 2025 and held it in 1 quarter. The position peaked at $7 in Q4 2025. 213 funds tracked by Wall St. Rank hold QURE as of Q1 2026.

Cygnus Capital Advisors reported no remaining uniQure position as of Q1 2026 after selling out during the quarter.
Cygnus Capital Advisors sold 288 uniQure shares in Q1 2026, an estimated $7.
Cygnus Capital Advisors first reported a position in uniQure in Q4 2025 and held it in 1 quarter.
Cygnus Capital Advisors's uniQure position peaked at $7 in Q4 2025.
213 funds tracked by Wall St. Rank held uniQure as of Q1 2026.

Based on Cygnus Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.